Prodromal Parkinson's Disease: What We Know and What We do Not Know

Prodromal Parkinson's Disease (PD) represents a critical phase preceding the clinical onset of the disease, characterized by subtle and often non-motor symptoms that precede the classic motor manifestations. Understanding this prodromal phase is essential for early diagnosis, intervention, and potentially altering the disease course. This narrative review aims to elucidate the current knowledge on the prodromal phase of PD, highlighting known biomarkers, genetic predispositions, and environmental factors that contribute to early detection. Furthermore, it examines the limitations and gaps in our understanding, including the variability in prodromal symptoms, challenges in identifying definitive biomarkers, and the need for longitudinal studies. By synthesizing the existing literature, this review provides a comprehensive overview of what we know about prodromal PD and underscores the areas that require further research to enhance early diagnostic accuracy and develop preventative strategies.

Authors

Institutions

Publication Details

Journal
Brazilian Journal of Clinical Medicine and Review
Published
2024-09-03
DOI
https://doi.org/10.52600/2965-0968.bjcmr.2025.3.1.bjcmr13
Primary Topic
Parkinson's Disease Mechanisms and Treatments
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Prodromal Parkinson's Disease: What We Know and What We do Not Know

Júlio César Claudino dos Santos, Carolina Vieira Naia, Luana Passos Oliveira, Flávio de Lima Filho et al.
Brazilian Journal of Clinical Medicine and Review
Parkinson's Disease Mechanisms and Treatments
article

Prodromal Parkinson's Disease: What We Know and What We do Not Know

Júlio César Claudino dos Santos, Carolina Vieira Naia, Luana Passos Oliveira, Flávio de Lima Filho, Giovana de Souza Faria, A Dionisio
article en

Abstract

Prodromal Parkinson's Disease (PD) represents a critical phase preceding the clinical onset of the disease, characterized by subtle and often non-motor symptoms that precede the classic motor manifestations. Understanding this prodromal phase is essential for early diagnosis, intervention, and potentially altering the disease course. This narrative review aims to elucidate the current knowledge on the prodromal phase of PD, highlighting known biomarkers, genetic predispositions, and environmental factors that contribute to early detection. Furthermore, it examines the limitations and gaps in our understanding, including the variability in prodromal symptoms, challenges in identifying definitive biomarkers, and the need for longitudinal studies. By synthesizing the existing literature, this review provides a comprehensive overview of what we know about prodromal PD and underscores the areas that require further research to enhance early diagnostic accuracy and develop preventative strategies.

Brazilian Journal of Clinical Medicine and ReviewVol. 3(1)
Centro Universitário Barão de Mauá (BR), Universitario Francisco de Asís (UY)
Openalex Percentile: Top 77%
Parkinson's Disease Mechanisms and Treatments
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Prodromal Parkinson's Disease: What We Know and What We do Not Know — Júlio César Claudino dos Santos, Carolina Vieira Naia, et al. · Brazilian Journal of Clinical Medicine and Review (2024) | TGRS Research Map | TGRS